PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Invesco Dynamic Biotechnology & Genome ETF (PBE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINUS73935X8561
CUSIP46137V787
IssuerInvesco
Inception DateJun 23, 2005
RegionNorth America (U.S.)
CategoryHealth & Biotech Equities
Leveraged1x
Index TrackedDynamic Biotech & Genome Intellidex Index (AMEX)
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

PBE features an expense ratio of 0.59%, falling within the medium range.


Expense ratio chart for PBE: current value at 0.59% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.59%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: PBE vs. PJP, PBE vs. ARKG, PBE vs. IBB, PBE vs. IBBQ, PBE vs. BBH, PBE vs. IDNA, PBE vs. FBT, PBE vs. QQQ, PBE vs. XBI, PBE vs. IYH

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Invesco Dynamic Biotechnology & Genome ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%JuneJulyAugustSeptemberOctober
9.46%
16.23%
PBE (Invesco Dynamic Biotechnology & Genome ETF)
Benchmark (^GSPC)

Returns By Period

Invesco Dynamic Biotechnology & Genome ETF had a return of 4.54% year-to-date (YTD) and 29.99% in the last 12 months. Over the past 10 years, Invesco Dynamic Biotechnology & Genome ETF had an annualized return of 3.50%, while the S&P 500 had an annualized return of 11.23%, indicating that Invesco Dynamic Biotechnology & Genome ETF did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date4.54%22.29%
1 month-1.45%1.65%
6 months13.03%15.83%
1 year29.99%39.98%
5 years (annualized)6.21%13.99%
10 years (annualized)3.50%11.23%

Monthly Returns

The table below presents the monthly returns of PBE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-2.32%1.95%-1.25%-5.94%3.98%2.41%8.27%2.42%-2.85%4.54%
20235.17%-4.73%-1.34%-0.28%-3.67%1.66%3.53%-2.98%-7.35%-6.04%9.34%12.36%3.71%
2022-14.72%-0.76%2.92%-9.33%1.26%1.39%5.68%-0.89%-2.55%7.62%5.03%-4.69%-10.83%
20217.92%-2.00%-0.47%2.17%-2.92%5.61%-2.50%4.10%-4.65%0.31%-6.10%1.03%1.54%
2020-3.25%-7.27%-7.14%14.54%8.99%0.39%1.26%-0.56%-3.50%-0.14%12.99%9.77%25.66%
201911.64%4.32%0.67%-5.43%-7.25%10.56%-1.10%-5.54%-5.25%7.72%8.44%0.92%18.65%
201810.54%-1.84%-3.81%-2.32%7.03%6.32%5.03%4.47%-0.96%-13.80%3.42%-11.19%-0.19%
20175.00%7.07%-2.95%1.92%-2.99%9.78%1.97%4.70%2.40%-6.63%-0.99%2.17%22.28%
2016-23.73%-4.33%3.85%2.72%3.51%-9.12%11.38%-2.52%4.53%-10.92%9.02%-4.46%-22.90%
20155.52%3.49%0.58%-3.97%9.17%1.15%1.93%-9.93%-14.45%9.40%1.94%-0.30%1.72%
201413.25%7.60%-7.80%-4.66%-0.76%11.56%-1.65%11.14%-3.18%7.94%1.74%-1.10%36.34%
20138.60%-0.32%6.07%7.93%5.41%-3.16%13.15%0.70%6.53%0.29%8.05%-2.50%62.24%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PBE is 34, suggesting that the investment has average results relative to other ETFs in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of PBE is 3434
Combined Rank
The Sharpe Ratio Rank of PBE is 3535Sharpe Ratio Rank
The Sortino Ratio Rank of PBE is 3737Sortino Ratio Rank
The Omega Ratio Rank of PBE is 3232Omega Ratio Rank
The Calmar Ratio Rank of PBE is 2929Calmar Ratio Rank
The Martin Ratio Rank of PBE is 3737Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


PBE
Sharpe ratio
The chart of Sharpe ratio for PBE, currently valued at 1.61, compared to the broader market-2.000.002.004.006.001.61
Sortino ratio
The chart of Sortino ratio for PBE, currently valued at 2.36, compared to the broader market0.005.0010.002.36
Omega ratio
The chart of Omega ratio for PBE, currently valued at 1.28, compared to the broader market1.001.502.002.503.003.501.28
Calmar ratio
The chart of Calmar ratio for PBE, currently valued at 0.84, compared to the broader market0.005.0010.0015.000.84
Martin ratio
The chart of Martin ratio for PBE, currently valued at 7.68, compared to the broader market0.0020.0040.0060.0080.00100.00120.007.69
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 3.43, compared to the broader market-2.000.002.004.006.003.43
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 4.52, compared to the broader market0.005.0010.004.52
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.64, compared to the broader market1.001.502.002.503.003.501.64
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 3.17, compared to the broader market0.005.0010.0015.003.17
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 22.22, compared to the broader market0.0020.0040.0060.0080.00100.00120.0022.22

Sharpe Ratio

The current Invesco Dynamic Biotechnology & Genome ETF Sharpe ratio is 1.61. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Invesco Dynamic Biotechnology & Genome ETF with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00JuneJulyAugustSeptemberOctober
1.61
3.43
PBE (Invesco Dynamic Biotechnology & Genome ETF)
Benchmark (^GSPC)

Dividends

Dividend History

Invesco Dynamic Biotechnology & Genome ETF provided a 0.05% dividend yield over the last twelve months, with an annual payout of $0.03 per share.


0.00%0.20%0.40%0.60%0.80%1.00%1.20%$0.00$0.10$0.20$0.30$0.40$0.50$0.602014201520162017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM2023202220212020201920182017201620152014
Dividend$0.03$0.01$0.00$0.00$0.03$0.00$0.00$0.27$0.15$0.57$0.28

Dividend yield

0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%0.55%

Monthly Dividends

The table displays the monthly dividend distributions for Invesco Dynamic Biotechnology & Genome ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.02$0.00$0.00$0.01$0.00$0.00$0.00$0.00$0.03
2023$0.00$0.00$0.00$0.00$0.00$0.01$0.00$0.00$0.00$0.00$0.00$0.00$0.01
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.03$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$0.00$0.00$0.06$0.00$0.00$0.22$0.00$0.00$0.00$0.00$0.00$0.00$0.27
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03$0.00$0.00$0.12$0.15
2015$0.00$0.00$0.00$0.00$0.00$0.12$0.00$0.00$0.14$0.00$0.00$0.31$0.57
2014$0.23$0.00$0.00$0.04$0.00$0.00$0.00$0.28

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctober
-17.85%
-0.54%
PBE (Invesco Dynamic Biotechnology & Genome ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Invesco Dynamic Biotechnology & Genome ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Invesco Dynamic Biotechnology & Genome ETF was 45.69%, occurring on Mar 9, 2009. Recovery took 407 trading sessions.

The current Invesco Dynamic Biotechnology & Genome ETF drawdown is 17.85%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-45.69%Oct 16, 2007351Mar 9, 2009407Oct 18, 2010758
-44.56%Jul 20, 2015238Jun 27, 20161022Jul 20, 20201260
-37.84%Feb 9, 2021340Jun 14, 2022
-26.36%May 13, 201160Aug 8, 2011227Jul 2, 2012287
-21.12%Feb 28, 200697Jul 17, 2006192Apr 23, 2007289

Volatility

Volatility Chart

The current Invesco Dynamic Biotechnology & Genome ETF volatility is 4.63%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%JuneJulyAugustSeptemberOctober
4.63%
2.71%
PBE (Invesco Dynamic Biotechnology & Genome ETF)
Benchmark (^GSPC)